DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation – Edwards Lifesciences (NYSE:EW)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered…

Continue ReadingDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation – Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP – Edwards Lifesciences (NYSE:EW)

RADNOR, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed…

Continue ReadingEdwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP – Edwards Lifesciences (NYSE:EW)

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman – Edwards Lifesciences (NYSE:EW)

SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation EW investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024…

Continue ReadingAfter Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman – Edwards Lifesciences (NYSE:EW)

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Edwards Lifesciences Corporation – Edwards Lifesciences (NYSE:EW)

SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences…

Continue ReadingInvestor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Edwards Lifesciences Corporation – Edwards Lifesciences (NYSE:EW)